Mikael Granlund scored with 58 seconds remaining in overtime and the Anaheim Ducks extended their winning streak to three games with a 2-1 overtime victory at home over the rival ...
Anaheim Ducks center Leo Carlsson will be sidelined for three to five weeks after undergoing a procedure to address a left thigh injury.
Management of geographic atrophy (GA) has changed with the introduction of retinal therapies aimed at slowing disease ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Bi opsy of the P rostate A voidance S ...
Ocugen, Inc. gene therapy outlook: key 2026 catalysts, Phase 2/3 eye-disease data, BLA plans to 2028, and risks. Click for ...
GlobalData is the parent company of Clinical Trials Arena. "Ocugen sets sights on Phase III after GA gene therapy win" was ...
Ocugen has announced positive preliminary 12-month data from its phase 2 ArMaDa trial evaluating OCU410 (AAV5-RORA) for the ...
Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. controlThere are no ...
Ocugen (OCGN) traded higher in the premarket on Thursday after the company said that OCU410, its gene therapy for an eye ...
Annexon (NASDAQ:ANNX) used its presentation at the 44th Annual J.P. Morgan Healthcare Conference to outline a set of ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. There was no significant difference between the rate of ...
Aviceda Therapeutics has hit a snag in its goal to deliver a new treatment for geographic atrophy (GA), an advanced form of dry age-related macular degeneration. The biotech’s lead asset, AVD-104, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results